-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We
-
://europepmc.org/article/MED/31561945 , https://europepmc.org/article/MED/39747019 Profile Master’s in bio-engineering, medicine, molecular biology, immunology, or related FELASA certification Experience in either
Enter an email to receive alerts for control-systems-engineering-"https:" positions